Lucid Group (NASDAQ:LCID) outlined a broad operational reset during its second-quarter 2026 earnings call, with newly appointed CEO Silvio Napoli saying the electric-vehicle maker is targeting approximately $1.4 billion in cash-flow improvements this year while reducing production, lowering inventor
News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
Lucid Group (LCID) delivered earnings and revenue surprises of -5.77% and +25.37%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Shares recently jumped 22% after Saudi Prince Alwaleed disclosed a 5% stake; the PIF remains Lucid’s largest shareholder with a 45% position.
Luxury electric car manufacturer Lucid (NASDAQ:LCID) will be reporting earnings this Tuesday afternoon. Here’s what to look for.
The stakes are high for Lucid's next earnings announcement.
Rivian just posted its cleanest quarterly beat in months and lifted full-year guidance, so why are shareholders waking up to an 8% drop while Lucid bleeds in sympathy and Tesla quietly holds its ground?
Rivian provided several key updates during its latest earnings announcement.
Both electric-vehicle makers need positive momentum to lift their struggling stocks.
Tesla just posted record deliveries and Wall Street still hammered the stock lower by 8%, exposing a growing divide between what the company ships today and what investors are actually paying for.
Barclays analyst Dan Levy believes updates about new R2 demand will be important for Rivian stock when the company reports Q2 earnings at the end of July.
Tesla is sitting 10% below where it started the year, but the options market and a rapidly changing cost structure tell a very different story about what happens after July 22.
Citi just trimmed its price target on Lucid Group (NASDAQ:LCID) to $14 from $17, while keeping a Buy rating. Analyst Michael Ward cited the company’s Q1 2026 miss and the withdrawal of its 2026 outlook, but argued the medium-term thesis remains intact. For long-term investors, the price target cut reads as a sobering near-term recalibration ... Citi Cuts Lucid Price Target to $14: Q1 Miss, Pulled Guidance Test the Saudi-Backed EV Maker
Lucid Diagnostics (NASDAQ:LUCD) reported first-quarter 2026 EsoGuard test volume above its pre-Medicare target range, while management said it continues to await a Medicare local coverage determination and is expanding efforts with the Department of Veterans Affairs, commercial payers and health sys
Lucid Drops After Earnings Reveal Delivery Weakness, Rising Losses
LCID posts wider-than-expected Q1 loss and misses estimates as write-downs, costs and supplier issues hit margins, even as revenues grow and liquidity gets a boost.
Lucid reported a first-quarter loss of almost $1 billion. Wall Street was looking for a loss of about $864 million.